Literature DB >> 15469848

Assembling a gene regulatory network for specification of the B cell fate.

Kay L Medina1, Jagan M R Pongubala, Karen L Reddy, David W Lancki, Rodney Dekoter, Matthias Kieslinger, Rudolf Grosschedl, Harinder Singh.   

Abstract

The generation of B lymphocyte precursors is dependent on the combinatorial action of the transcription factors PU.1, Ikaros, E2A, EBF, and Pax-5. Loss of PU.1 results in a severe reduction in Flk2+, IL-7R+ lymphoid progenitors as well as impaired expression of EBF and Pax-5. Restoration of EBF expression facilitates rapid generation of pro-B cells from PU.1-/- progenitors. Molecular analysis suggests that PU.1 directly participates in regulation of the EBF gene. Although PU.1 is dispensable for expression of most early B lineage genes, it is required for CD45R/B220. Using EBF-/- mutant progenitors, we show that EBF induces Pax-5 and the early program of B lineage gene expression. Importantly, Pax-5 does not rescue B cell development from either PU.1-/- or EBF-/- progenitors. Pax-5 expression and function are contingent on EBF. Based on these results, we propose a hierarchical regulatory network for specification and commitment to the B cell fate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469848     DOI: 10.1016/j.devcel.2004.08.006

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  92 in total

Review 1.  Factors and networks that underpin early hematopoiesis.

Authors:  Elinore M Mercer; Yin C Lin; Cornelis Murre
Journal:  Semin Immunol       Date:  2011-09-18       Impact factor: 11.130

2.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.

Authors:  Ildiko Györy; Sören Boller; Robert Nechanitzky; Elizabeth Mandel; Sebastian Pott; Edison Liu; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2012-03-19       Impact factor: 11.361

Review 3.  Contingent gene regulatory networks and B cell fate specification.

Authors:  Harinder Singh; Kay L Medina; Jagan M R Pongubala
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

4.  Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.

Authors:  Hiromi Iwasaki; Chamorro Somoza; Hirokazu Shigematsu; Estelle A Duprez; Junko Iwasaki-Arai; Shin-Ichi Mizuno; Yojiro Arinobu; Kristin Geary; Pu Zhang; Tajhal Dayaram; Maris L Fenyus; Shannon Elf; Susan Chan; Philippe Kastner; Claudia S Huettner; Richard Murray; Daniel G Tenen; Koichi Akashi
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

5.  Interlinked fast and slow positive feedback loops drive reliable cell decisions.

Authors:  Onn Brandman; James E Ferrell; Rong Li; Tobias Meyer
Journal:  Science       Date:  2005-10-21       Impact factor: 47.728

6.  Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.

Authors:  Christoph Renné; Jose Ignacio Martin-Subero; Maren Eickernjäger; Martin-Leo Hansmann; Ralf Küppers; Reiner Siebert; Andreas Bräuninger
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

7.  Structure of an Ebf1:DNA complex reveals unusual DNA recognition and structural homology with Rel proteins.

Authors:  Nora Treiber; Thomas Treiber; Georg Zocher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2010-09-28       Impact factor: 11.361

8.  Hoxa9 regulates Flt3 in lymphohematopoietic progenitors.

Authors:  Kimberly Gwin; Elena Frank; Ayoko Bossou; Kay L Medina
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 9.  Transcriptional regulation of early B cell development.

Authors:  Daniel L Northrup; David Allman
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

10.  IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression.

Authors:  Kazu Kikuchi; Hirotake Kasai; Akiko Watanabe; Anne Y Lai; Motonari Kondo
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.